Supernus Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SUPN and other ETFs, options, and stocks.

About SUPN

Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products.

CEO

Jack A. Khattar

CEOJack A. Khattar

Employees

674

Employees674

Headquarters

Rockville, Maryland

HeadquartersRockville, Maryland

Founded

2005

Founded2005

Employees

674

Employees674

SUPN Key Statistics

Market cap

1.85B

Market cap1.85B

Price-Earnings ratio

29.99

Price-Earnings ratio29.99

Dividend yield

—

Dividend yield—

Average volume

728.03K

Average volume728.03K

High today

$33.35

High today$33.35

Low today

$32.50

Low today$32.50

Open price

$33.03

Open price$33.03

Volume

443.48K

Volume443.48K

52 Week high

$40.28

52 Week high$40.28

52 Week low

$27.05

52 Week low$27.05

People also own

Based on the portfolios of people who own SUPN. This list is generated using Robinhood data, and it’s not a recommendation.